Before the COVID pandemic, efforts to address the challenge of limited vaccine production on the continent yielded little success.
- Senior Research Officer & Co-Director, Vaccines For Africa Initiative, Faculty of Health Sciences, University of Cape Town
In Africa, it’s more rational to prioritise vaccine access, rapid rollout and community engagement, than pushing the narrative of vaccine-induced population immunity.
Several countries on the continent had introduced COVID-19 vaccination by early March 2021.
The African Vaccine Acquisition Task Team recently secured a provisional 270 million vaccine doses for African countries.
There are three promising COVID-19 trials.
The threat posed by measles is on the rise again in a number of countries in the world. One of them is the Democratic Republic of the Congo.
Contact Benjamin for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Location: Cape Town, South Africa
- Website
- X (formerly Twitter): @BenjaminKagina
- Article Feed
- ORCID
- Joined
